How well does acoustic plus electric processing work for those implanted with a new cochlear implant type, and how does it compare to electric-only processing?
Background: Cochlear implants (CI) have been highly successful in restoring hearing in individuals with postlingual deafness and in children who are prelingually deafened and implanted early. Until recently, those with residual hearing, usually in the low-frequency (LF) apical region of the cochlea, have not been candidates for standard CIs because implantation destroys most useful remaining hearing. A CI that could provide stimulation to the damaged high-frequency regions of the cochlea while preserving LF hearing offers numerous advantages.
Explore this issue:April 2016
Study design: Multicenter, longitudinal, single-subject FDA trial with 87 subjects who received a Nucleus Hybrid S8 CI in their poorer ear, running from 2002 to 2011 and involving 19 surgeons across 17 U.S. centers.
Setting: Arizona Ear Center, Phoenix; California Ear Institute, Palo Alto; Center for Hearing & Balance; Dallas Otolaryngology Associates, Dallas; Denver Ear Associates, Englewood, Colo.; House Ear Institute, Los Angeles; Indiana University School of Medicine, Indianapolis; Mayo Clinic, Rochester, Minn.; Michigan Ear Institute, Farmington Hills; Midwest Ear Institute, Indianapolis; New York University Cochlear Implant Center; University of California San Francisco; University of Florida, Gainesville; University of Iowa, Iowa City; University of Miami, Coral Gables, Fla.; University of Washington, Seattle; UT Southwestern Medical School, Dallas.